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Wild cervids can carry several infectious agents known to affect human or animal health. Often spillover from domestic animals is assumed and, conversely, wild cervids may constitute a reservoir for pathogens causing disease in domestic ruminants or zoonoses in man. Screening in wild ruminants is essential to gain insight into the relations between sylvatic and domestic cycles of pathogens, and provides basic information for risk assessment for animal and human health in the region concerned.

Roe deer (*Capreolus capreolus*) are the only native cervid species living in the wild in Flanders (northern Belgium). Their population has increased over the last decennia and is currently estimated at about 25,000 with highest densities (up to 30/100 ha) in the eastern provinces Limburg, Antwerp and Flemish Brabant ([@CIT0001]). The small landscape structure of Flanders with intermixed nature, cultured land and urbanisation allows regular contact between roe deer and livestock or human dwellings. In Europe, roe deer are important feeding hosts for *Ixodes ricinus* ticks by which their population number and density is related to tick abundance and indirectly to the incidence of tick-borne infections.

Before the present study, only sporadic data about the prevalence of infectious agents in roe deer were generated in Flanders. Serologic methods allow to screen for multiple agents in one single blood sample in a cost-effective way, even after clearance of the agent from the host. Blood samples of wild cervids are usually collected during hunting activities. In contrast to the battue method used in Wallonia (southern Belgium), in Flanders roe deer are hunted one by one, hampering the continuous presence of an experienced sampler and resulting in a much slower sample collection. In such conditions and in the absence of a continued surveillance program, an optimal use of the sera is desirable by screening for a broad range of infectious agents. The objective of the present study was to find serologic evidence on the exposure of roe deer in Flanders to 13 infectious agents with economic impact in animals or zoonotic impact in man. Former studies in Europe in roe and red deer reported a broad range of serologic results for the 13 agents examined ([Supplementary file 1](http://www.infectionecologyandepidemiology.net/index.php/iee/rt/suppFiles/29862/0)).

Materials and methods {#S0002}
=====================

In 12 Flemish hunting areas ([Fig. 1](#F0001){ref-type="fig"}), from October 2008 to March 2013, instructed hunters collected 195 blood samples from the v. jugularis, v. cava caudalis, or hearth of roe deer, soon after the killing. If sampling from the veins was impossible, free blood from the body cavities was collected. Nine more samples were obtained during necropsy of culled or found-dead roe deer. One last sample came from a sick roe deer fawn in a rescue centre. For each animal sampled, the sex, the estimated age based on the tooth wear, the area of origin, and the date of sampling were recorded. The samples were cooled at 2--4°C, and on arrival at the lab were centrifuged for 10 min at 4,000 rpm. Heavily contaminated or decomposed samples were discarded. After dividing each serum in multiple Eppendorff tubes, the sera were kept at −20°C until analysis. The sera were examined for antibodies to 13 infectious agents by means of the tests listed in [Table 1](#T0001){ref-type="table"}. Different numbers of sera were tested for the various pathogens depending on the available volumes.

![Geographic origin (12 sampling areas) of roe deer sera examined for antibodies against 13 infectious agents in Flanders (Belgium). (Modified from: VDAB, 2015)](IEE-5-29862-g001){#F0001}

###### 

Serologic methods applied for the detection of antibodies against 13 infectious agents in roe deer sera

                                                    Cut-off                  
  ------- -------------------- -------------------- --------- -------------- --------
  MAP     iELISA (Pourquier)   G-HRP                SP        \<60           \>70
          iELISA (IDEXX)       G-HRP                SP        \<45           \>55
  BRU     iELISA               G-HRP                IU        \<2            \>2
  LEPT    MAT                  --                   --        --             --
  COX     iELISA               G-HRP                SP        \<40           \>40
  ANA     IFA                  Anti-deer IgG FITC   Titre     \<1/64         \>1/64
  CHL     iELISA               Anti-bov IgG HRP     SP        \<50           \>60
  BVDV1   VNT                  --                   Titre     \>1/10         \<1/10
  BHV1    VNT                  --                   Titre     \>1/2          \<1/2
  BTV     cELISA               --                   PN        \>75           \<66
  TBEV    VNT:RFFIT            --                   DIL~50~   \<10           \>15
  SBV     VNT                  --                   Titre     \>1/8          \<1/8
  TOX     iELISA               Anti-deer IgG HRP              OD per plate   
  NEO     iELISA               G-HRP                SP        \<41           \>50

G-HRP: protein G horseradish peroxidase (all species); FITC: fluorescein isothiocyanate; S/P: sample/positive control optical density ratio at 450 nm (OD450), determined as: 100× (sample OD450 -- negative control OD450/average 2 positive controls OD450 -- negative control OD450); IU: international units, corresponding to dilutions (standard curve based on six dilutions of a reference serum: 1/270 to 1/8340); PN: percent negativity compared to the negative kit control; DIL~50~: dilution at which 50% of the virus is neutralised; OD per plate: for each plate separately: mean corrected OD450 of three negative reference sera + 3× standard deviation OD450.

MAP: *Mycobacterium avium* subsp. *paratuberculosis*; BRU: *Brucella* sp.; COX: *Coxiella burnetii*; LEPT: *Leptospira*; ANA: *Anaplasma phagocytophilum*; CHL: *Chlamydia abortus*; BVDV1: bovine viral diarrhoea virus 1; BHV1: bovine herpesvirus 1; BTV: bluetongue virus; TBEV: tick-borne encephalitis virus; SBV: Schmallenberg virus; TOX: *Toxoplasma gondii*; NEO: *Neospora caninum*.

***Mycobacterium avium* subsp. *paratuberculosis*** (MAP) antibodies were detected by means of an indirect enzyme-linked immunosorbent assay (iELISA) in which the sera are first absorbed with *Mycobacterium phlei* antigen ([@CIT0002]). Two commercial tests, ELISA paratuberculosis antibody screening (Institut Pourquier, Monpellier, France) and IDEXX paratuberculosis screening Ab test (IDEXX Laboratories, Westbrook, Maine, USA), were used successively, due to a stock rupture of the first. Sera were tested for ***Brucella abortus*** antibodies with iELISA, using strain Weybridge 99 (*B. abortus* biotype 1) as antigen ([@CIT0003]). For ***Coxiella burnetii*** antibodies, samples were tested with the iELISA kit LSI Fièvre Q Ruminants Serum^®^ (Laboratoire Service International, Lissieu, France), according to the manufacturer\'s instructions ([@CIT0004]). Antibodies to **Leptospira** were looked up with the microscopic agglutination test (MAT), using live cultures as antigens ([@CIT0005]). A panel of 12 antigens was used, representing the most prevalent serogroups in Belgium: *grippotyphosa, canicola, pomona, ballum, icterohaemorrhagiae, javanica (*syn*. poi), australis, autumnalis, bataviae, pyrogenes, tarassovi, sejroe*. Results were expressed as positive/negative at dilution 1/100. For ***Anaplasma phagocytophilum***, sera were tested with an indirect fluorescent antibody test (IFA) (*A. phagocytophilum* IFA IgG (OUS) (Focus Diagnostics, Cypress, California, USA) according to the manufacturer\'s specifications, but with an anti-deer IgG fluorescein isothyocyanate (FITC)-labelled conjugate (KPL Inc., Gaithersburg, Maryland, USA). For ***Chlamydia abortus*** antibodies, sera were analysed with iELISA (ID Screen *Chlamydia abortus*, ID Vet Innovative Diagnostics, Montpellier, France) according to the manufacturer\'s instructions. In-house virus neutralisation tests (VNTs) were used to detect antibodies against the **bovine viral diarrhoea virus 1 (BVDV1)**, strain NADL ([@CIT0006]), and against **bovine herpes virus 1 (BHV1)** ([@CIT0007]). Titres were expressed as the reciprocal of the highest serum dilution yielding virus growth neutralisation. Antibodies to the VP7 group antigen of **bluetongue virus (BTV)** were looked up by means of the ID Screen Bluetongue Competition assay (ID VET, Montpellier, France), according to the manufacturer\'s instructions. Antibodies to **tick-borne encephalitis virus (TBEV)** were searched for with an in-house rapid fluorescent focus inhibition (RFFIT) seroneutralisation test ([@CIT0008]). Neutralising antibody titres were expressed in DIL~50~ which represents the dilution at which 50% of the virus, dosed at 0.8--1.4 log TCID~50~ (tissue culture infective dose), is neutralised ([@CIT0009]). An in-house VNT was used to detect antibodies against **Schmallenberg virus (SBV)**. Titres were expressed as the reciprocal of the highest serum dilution yielding virus growth neutralisation ([@CIT0010]). For ***Toxoplasma gondii***, an in-house iELISA detecting antibodies against the SAG1 tachyzoite surface antigen (IBL Int., Hamburg, Germany) was used as described before ([@CIT0011]). Sera were tested for the presence of anti-***Neospora caninum*** IgG using the ID Screen *N. caninum* indirect ELISA (IDVet, Montpellier, France) according to the manufacturer\'s instructions ([@CIT0012]). The antigen used in this test is a whole *N. caninum* extract.

For *C. abortus*, anti-bovine IgG horseradish peroxidase (HRP) and, for *T. gondii*, anti-deer IgG HRP were used as the conjugates. For all the other iELISA tests, 'all species' protein G-HRP was used. The conjugates were a component of the test kits mentioned, except for the in-house tests for *Brucella* (Thermo Scientific, Erembodegem, Belgium) and *T. gondii* (KPL Inc., Gaithersburg, Maryland, USA). In the ELISA\'s for MAP, *B. abortus*, *C. burnetii*, *C. abortus*, BTV, *N. caninum* and the VNTs for BVDV1, BHV1 and SBV, the cut-off values for domestic ruminants were applied. For the *A. phagocytophilum* IFA test, the cut-off value for human sera, as supplied by the manufacturer, was used. For BTV, the cut-off as described by Vandenbussche et al. ([@CIT0013]) was used. For the TBEV RFFIT, sera with DIL~50~\<10 were considered negative, between 10 and 15 borderline, and \>15 positive ([@CIT0008]). For *T. gondii*, cut-off values were determined for each plate separately after comparison with three negative and two positive sera as determined by the Sabin Feldman lysis test.

For all the results, confidence intervals ([Table 2](#T0002){ref-type="table"}) for proportion of number positive (or suspected) versus number tested were calculated. For the agents showing a high seroprevalence, the log-likelihood ratio ([Tables 3](#T0003){ref-type="table"} and [4](#T0004){ref-type="table"}) test for contingency tables was used to analyse whether seropositivity was dependent on sex, age, and geographical origin of the samples; *p*\<0.05 indicates significant difference between sexes, ages, or sampling regions.

###### 

Numbers of roe deer sera examined (*N*), absolute numbers and percentages of seropositive (+) and doubtful (susp) results, and 95% confidence intervals (CIs)

  -------------------------------------------------------------------------------------------------
            MAP   BRU   COX   LEPT   ANA    CHL    BVDV1   BHV 1   BTV   TBEV   SBV    TOX    NEO
  --------- ----- ----- ----- ------ ------ ------ ------- ------- ----- ------ ------ ------ -----
  *N*       171   129   171   177    190    178    159     130     165   98     111    169    168

  \+        7     0     2     3      87     12     2       0       0     5      31     73     8

  \% +      4.1   0.0   1.2   1.7    45.8   6.7    1.3     0.0     0.0   5.1    27.9   43.2   4.8

  95% CI\   1.7   0.0   0.1   0.4    38.6   3.5    0.2     0.0     0.0   0.0    19.8   35.6   2.1
  low                                                                                         

  95% CI\   8.3   2.8   4.2   4.9    53.2   11.5   4.5     2.8     2.2   11.5   37.2   51.0   9.2
  high                                                                                        

  Susp      2                               4                      5                          

  \% susp   1.2                             2.2                    3.0                        

  95% CI\   0.1                             0.6                    1.0                        
  low                                                                                         

  95% CI\   4.2                             5.7                    6.9                        
  high                                                                                        
  -------------------------------------------------------------------------------------------------

MAP: *Mycobacterium avium* subsp. *paratuberculosis*; BRU: *Brucella* sp.; COX: *Coxiella burnetii*; LEPT: *Leptospira*; ANA: *Anaplasma phagocytophilum*; CHL: *Chlamydia abortus*; BVDV1: bovine viral diarrhoea virus 1; BHV1: bovine herpesvirus 1; BTV: bluetongue virus; TBEV: tick-borne encephalitis virus; SBV: Schmallenberg virus; TOX: *Toxoplasma gondii*; NEO: *Neospora caninum*.

###### 

Comparison in seroprevalence between sexes, ages, and geographical origin of roe deer

               ANA             TBEV            SBV             TOX             NEO                                               
  ------------ --------------- --------------- --------------- --------------- --------------- ------- -------- -------- ------- -------
  Sex          85/184          46.2%           5/95            5.3%            30/108          27.8%   69/164   42.1%    8/163   4.9%
               LR: *p*=0.641   LR: *p*=0.304   LR: *p*=0.828   LR: *p*=0.733   LR: *p*=0.477                                     
  M            45/94           47.9%           2/59            3.4%            17/63           27.0%   33/81    40.7%    3/81    3.7%
  F            40/90           44.4%           3/36            8.3%            13/45           28.9%   36/83    43.4%    5/82    6.1%
  Age (year)   83/182          45.6%           5/96            5.2%            31/108          28.7%   67/161   41.6%    8/160   5.0%
               LR: *p*=0.528   LR: *p*=0.07    LR: *p*=0.734   LR: *p*=0.417   LR: *p*=0.026                                     
  \<1          21/43           48.8%           2/15            13.3%           6/21            28.6%   16/38    42.1%    0/38    0.0%
  1            27/54           50.0%           0/35            0.0%            9/37            24.3%   16/47    34.0%    1/47    2.1%
  \>1          35/85           41.2%           3/46            6.5%            16/50           32.0%   35/76    46.1%    7/75    9.3%
  Region       81/181          44.8%           5/93            5.4%            31/106          29.2%   69/160   43.1%    6/159   3.8%
               LR: *p*=0.221   LR: *p*=0.635   LR: *p*=0.068   LR: *p*=0.472   LR: *p*=0.843                                     
  1            0/2             0.0%                                                                    1/2      50.0%    0/2     0.0%
  2            8/16            50.0%           1/4             25.0%           1/3             33.3%   6/16     37.5%    2/16    12.5%
  3            4/7             57.1%           0/4             0.0%            0/4             0.0%    2/5      40.0%    0/5     0.0%
  4            3/4             75.0%           0/1             0,0%            1/2             50.0%   2/3      66.7%    0/3     0.0%
  5            3/11            27.3%                                           0/3             0.0%    7/11     63.6%    1/11    9.1%
  6            0/2             0.0%                                            0/2             0,0%    1/2      50.0%    0/2     0.0%
  7            25/50           50.0%           2/24            8.3%            4/30            13.3%   15/49    30.6%    2/49    4.1%
  8            5/7             71.4%           0/2             0.0%            1/3             33.3%   3/7      42.9%    0/7     0.0%
  9            12/33           36.4%           1/11            9.1%            8/18            44.4%   14/26    53.8%    0/25    0.0%
  10           21/47           44.7%           1/47            2.1%            16/41           39.0%   16/37    43.2%    1/37    2.7%
  11           0/1             0.0%                                                                    1/1      100.0%   0/1     0.0%
  12           0/1             0.0%                                                                    1/1      100.0%   0/1     0.0%

ANA: *Anaplasma phagocytophilum;* TBEV: tick-borne encephalitis virus; SBV: Schmallenberg virus; TOX: *Toxoplasma gondii*; NEO: *Neospora caninum*; LR=log-likelihood ratio.

###### 

Comparison of numbers positive and doubtful reacting sera between sexes, ages, and geographical origin of roe deer

           MAP             CHL                                                      
  -------- --------------- --------------- ------- ------- -------- ------- ------- ------
  Sex      7/165           4.2%            2/165   1.2%    10/173   5.8%    4/173   2.3%
           LR: *p*=0.529   LR: *p*=0.029                                            
  M        5/84            6.0%            1/84    1.2%    4/92     4.3%    0/92    0.0%
  F        2/81            2.5%            1/81    1.2%    6/81     7.4%    4/81    4.9%
  Age      7/163           4.3%            2/163   1.2%    11/172   6.4%    4/172   2.3%
           LR: *p*=0.725   LR: *p*=0.786                                            
  \<1      1/39            2.6%            1/39    2.6%    4/38     10.5%   1/38    2.6%
  1        2/47            4.3%            0/47    0.0%    2/53     3.8%    1/53    1.9%
  \>1      4/77            5.2%            1/77    1.3%    5/81     6.2%    2/81    2.5%
  Region   7/166           4.2%            2/166   1.2%    12/171   7.0%    4/171   2.3%
           LR: *p*=0.430   LR: *p*=0.979                                            
  1                                                        0/2      0.0%    0/2     0.0%
  2        0/13            0.0%            1/13    7.7%    2/15     13.3%   0/15    0.0%
  3        0/7             0.0%            0/7     0.0%    0/5      0.0%    0/5     0.0%
  4        0/3             0.0%            0/3     0.0%    0/3      0.0%    0/3     0.0%
  5        1/10            10.0%           0/10    0.0%    1/10     10.0%   0/10    0.0%
  6        0/2             0.0%            1/2     50.0%   0/2      0.0%    0/2     0.0%
  7        2/49            4.1%            0/49    0.0%    2/50     4.0%    1/50    2.0%
  8        0/7             0.0%            0/7     0.0%    0/7      0.0%    0/7     0.0%
  9        0/33            0,0%            0/33    0.0%    2/29     6.9%    2/29    6.9%
  10       4/40            10.0%           0/40    0.0%    5/47     10.6%   1/47    2.1%
  11       0/1             0.0%            0/1     0.0%                             
  12       0/1             0.0%            0/1     0.0%    0/1      0.0%    0/1     0.0%

MAP: Mycobacterium avium subsp. paratuberculosis; CHL: Chlamydia abortus; LR: log-likelihood ratio.

Results {#S0003}
=======

From 205 sera collected, 15 (7%) had to be discarded due to putrefaction. A total of 190 sera useful for analysis were obtained over the whole sampling period 2008--2013. [Table 2](#T0002){ref-type="table"} shows the numbers and percentages of positive/doubtful reacting sera. As our results did not allow normal approximation, exact confidence intervals were determined, explaining the asymmetric intervals.

The highest prevalences (\>25%) found were for *A. phagocytophilum*, SBV, and *T. gondii*. A lower prevalence (3--10%) was found for MAP (7/171: 2/60 Pourquier, 5/111 IDEXX), *C. abortus* (12/178), TBEV (5/98), and *N. caninum* (8/168). The lowest prevalences (1--2%) were found for *C. burnetii* (2/171), Leptospira (3/177), and BVDV1 (2/159). Doubtful results, i.e. between the negative and positive cut-off value, were obtained for MAP (2/171), *C. abortus* (4/178), and BTV (5/165). For BTV, no seropositives were found. No antibodies were found against *B. abortus* and BHV1.

For the agents with a seroprevalence higher than 2%, comparison between sexes, ages, and regions of sampling is shown in [Tables 3](#T0003){ref-type="table"} and [4](#T0004){ref-type="table"}. Sera with unknown sex, age or region were not included.

Concerning the doubtful results for *C. abortus*, a significant difference between sexes could be noticed (higher seroprevalence in females). For *N. caninum*, the difference between ages is significant. An age dependence for TBEV and a region dependence for SBV are suggested by the results, albeit below the threshold of significance. For SBV, two sampling periods yielding different results could be distinguished: period 1: 02/2009-09/2011; period 2: 01/2012-03/2013 (no sera were obtained from October to January due to the legal hunting periods in Flanders): all the seropositive sera were found in period 2 exclusively (period 1: 0/63 or 0%; period 2: 31/49 or 63%).

Discussion {#S0004}
==========

None of the serologic tests used has been validated for use in roe deer, and exact information about their performances in species other than domestic ruminants is lacking. The use of all species IgG in the conjugate of the iELISAs enables the use of these tests in wild cervids, but for lack of species-specific cut-off values, those for domestic ruminants were applied, like in many similar studies. In most of the results, a clear distinction could be made between negative and positive reacting sera. Nevertheless, a small number of doubtful results were obtained for MAP, *C. abortus*, and BTV ([Tables 2](#T0002){ref-type="table"} and [4](#T0004){ref-type="table"}). In a competitive binding assay, Tryland et al. ([@CIT0014]) found for roe deer and red deer IgG a respectively higher and lower affinity for protein G as compared to cattle IgG. Also elk (*Cervus canadensis*) IgG shows a higher protein G affinity ([@CIT0015]). This implies that when protein G is used in the conjugate for the iELISA tests, cut-off values for roe deer sera could be slightly adapted as compared to cattle sera (see below).

The iELISA tests commonly used for **MAP** cross-react with other mycobacteria. By absorbing the sera with *M. phlei* antigen, genetically related to MAP, cross-reactions are eliminated and an increased specificity is obtained ([@CIT0002]). The sensitivity of the ELISA is very low as less than 50% of infected cattle (confirmed by isolation) were found seropositive ([@CIT0016]). Poor sensitivity also limits the utility for surveillance in wild cervids ([@CIT0017]). For example, Nebbia et al. ([@CIT0018]) found only one seropositive among 10 PCR positive red deer in the Italian Alps, and in a serosurvey in a paratuberculosis affected fallow deer herd in Spain no seropositive animals could be detected ([@CIT0019]). The distribution of optical densities we obtained allowed to distinguish positive and negative samples, except for two 'doubtful' results (IDEXX) between the negative and positive cut-off. The higher affinity of protein G for roe deer IgG can be taken into account ([@CIT0014]): by slightly increasing the negative and positive cut-off values (expressed as sample/positive control optical density ratio), i.e. from 55 to 60% for the positives and from 45 to 50% for the negatives, the two doubtful sera become negative but one of the formerly positive sera becomes 'doubtful', reducing the final number of doubtful results to one. Comparison of serologic results for MAP in wild cervids in Europe is an approximation, given the use of different antigens, antibodies, and cut-off values and the lack of validation of the tests in species other than cattle ([@CIT0015], [@CIT0020]). The seroprevalence reported in roe deer in Europe is generally low, reaching up to 12% ([@CIT0014]), in contrast to red deer where 30% seropositives and clinically affected animals are found in areas where MAP is endemic in cattle ([@CIT0020]). In Wallonia, Linden et al. ([@CIT0021]) found 1.13% seropositive roe deer and 7.26% red deer, only the latter showing signs and lesions of paratuberculosis. The herd seroprevalence in Belgian cattle is 22%, and at animal level in dairy cattle the prevalence is up to 3.9% ([@CIT0022]). Given the poor sensitivity of the test, our results (4.1% positives) confirm that MAP is endemic in roe deer in Flanders and that maintenance of the infection in roe deer cannot be excluded.

***B. abortus***: Sensitivity of the iELISA for *Brucella* antibodies is high, but poor specificity and the non-validation for use in wildlife necessitate confirmation by the Rose Bengal Test for the seropositive results. For in-depth epidemiological studies, the isolation of *Brucella* remains the gold standard ([@CIT0023], [@CIT0024]). *Brucella* appears to be of little importance in cervids in Europe. Antibodies are generally absent in roe deer, while only 0.4% positives were found in red deer in Spain ([@CIT0025]). The absence of anti-*Brucella* antibodies in Flemish roe deer accords with other European studies, and indicates also that transmission of *B. suis* from wild boar is unlikely (*B. melitensis* does not occur in Northwestern Europe).

Of the serologic tests commonly used for ***C. burnetii***, the iELISA and immunofluorescence assay (IFA) are more sensitive than the complement fixation (CF) test ([@CIT0004]). *C. burnetii* seroprevalence in wild cervids in Europe is poorly documented but can reach 15% in roe deer and 29% in red deer ([@CIT0026]). In the Netherlands during the human epidemic (2007--2010), 23% of the roe deer examined were PCR positive, without signs of disease ([@CIT0027]). The antibody prevalence (1.2%) we found in roe deer in Flanders is low compared to domestic ruminants: in Belgian dairy cattle, the within-herd prevalence is 3.9% while the herd prevalence is 77% in dairy cattle and 13% in goats ([@CIT0022], [@CIT0028]). Differences in virulence of *C. burnetii* strains for different host species could play a role in the different seroprevalence between roe deer and cattle: *C. burnetii* field isolates from goat and bovine origin in Belgium showed a different replication rate in bovine macrophages suggesting host specificity ([@CIT0029]). Our findings do not indicate roe deer to be a reservoir for *C. burnetii* in Flanders.

The sensitivity of the MAT for **Leptospira** is limited as chronic carriers may have undetectable antibody titres. Moreover, in order to maximise the sensitivity, all the serogroups known to occur in the area studied have to be included. The specificity is good although significant cross-reactivity exists between serogroups ([@CIT0005]). The seroprevalence to leptospirosis in wild cervids in Europe is poorly documented, but is generally low (up to 7%) ([@CIT0030], [@CIT0031]). Consistently, our results confirm that roe deer in Flanders are insignificant carriers of *Leptospira*: 3/177 (1.7%) were positive. Two of the positives were collected on dead-found roe deer, an adult hind showing mycotic abscesses in the lungs, and a fawn. The lesions were not suggestive for leptospirosis. The third sample came from a male roe deer, over 1 year old, that also proved seropositive for MAP and *A. phagocytophilum*. Immune suppression or concurrent infections may have played a role in the seropositive animals. The serovars we found were *icterohaemorrhagiae*+*ballum* (from the hind and the fawn) and *grippotyphosa* (from the male). However, due to serological cross-reactivity between serovars and serogroups of *Leptospira*, identifying correctly the serovar would require isolation of the agent.

***A. phagocytophilum*****:** Serological cross-reactivity between *Anaplasma* species is known in both tests commonly used, the competitive ELISA and the IFA ([@CIT0032], [@CIT0033]). Yet *A. marginale*, *A. centrale*, and *A. ovis* are restricted to Mediterranean and Central--Eastern Europe and have not been reported in North--Western Europe until now ([@CIT0033]). False positives due to haemolysis can bias the test. Therefore, the high seroprevalence against *A. phagocytophilum*, although comparable to results of other European studies using the same method, can be questioned for field-collected samples being frequently haemolytic. Nevertheless, high seroprevalences mostly coincide with high PCR prevalences (up to 86%) in roe deer blood or spleen samples. In cervids, the seroprevalence reported is generally very high, and is higher in roe deer (up to 96%) than in red deer (up to 55%) ([@CIT0034]--[@CIT0036]). Like elsewhere in Europe, roe deer in Flanders appear to be highly exposed to *A. phagocytophilum* with a seroprevalence of 45.8%. Yet the importance for transmission to cattle has to be relativised as suggested by recent phylogenetic work. Three genotypic distinct groups of *A. phagocytophilum* have been identified, of which two include 98% of all the genotypes found in cattle, different of the genotypes found in roe deer ([@CIT0037]).

***C. abortus*****:** Serological data about *Chlamydia* infections in ruminants often refer to CF antibodies against the lipopolysaccharide (LPS) antigen common to all *Chlamydiaceae*. Aspecific cross-reactions are possible ([@CIT0038]). The antigen in the iELISA used here is a species-specific fragment of the major outer membrane protein (MOMP) of *C. abortus*. By using a MOMP- or polymorphic outer membrane protein (POMP)-based ELISA, a higher specificity for *C. abortus* and higher sensitivity are obtained ([@CIT0039]). Up to 20% seroprevalence was reported in roe deer for *C. abortus-*specific antibodies and 28% for *Chlamydiaceae* ([Supplementary file 1](http://www.infectionecologyandepidemiology.net/index.php/iee/rt/suppFiles/29862/0)). Though the impact on European wild ungulates is unknown, there is no doubt about their capacity of maintaining the infection ([@CIT0039]). We found 6.7% seropositives and 2.2% doubtful results for *C. abortus* antibodies. Even without including the doubtfuls, the seroprevalence in roe deer is higher than the highest prevalence found in domestic animals, being 4.05% in sheep (province of Limburg) and 4.23% in cattle (province of Walloon Brabant) ([@CIT0040]). Interestingly, a majority of our sera came from the province of Limburg. Yet there was no statistic difference in seropositive results between geographical origin of the samples (*p*=0.98). A significant difference in seroprevalence between sexes can be noticed on account of the four doubtful results (*p*=0.029; higher in females). Between-sex differences were reported in sheep and goats ([@CIT0041]) and in free-ranging yak (*Poephagus grunniens*), possibly linked to sexual transmission by males carrying *C. abortus* in their genital tract ([@CIT0042]). Other studies found no sex difference in *C. abortus* antibody prevalence in red and roe deer ([@CIT0039], [@CIT0043]). The higher prevalence than in domestic ruminants we found in Flemish roe deer supports their reservoir role for *C. abortus*.

Antigenic variability in some of the epitopes of viral antigen contributes to the complexity in classification, clinical behaviour, and diagnosis of **BVDV** strains ([@CIT0044], [@CIT0045]). VNT is considered the gold standard for antibody testing against BVDV. It offers reliable information on the circulation of virus strains antigenically related to the NADL strain of BVDV1 we used. Antibodies to less related strains ((e.g. certain BVDV2 strains) may still cross-react, but low antibody levels may be missed. To broaden the reactivity, testing against more than one isolate, e.g. both a BVDV1 and a BVDV2 strain, is needed. In Belgian cattle, BVDV1 is the most prevalent virus, the herd seroprevalence being 47% and the prevalence at animal level 33% ([@CIT0046]). Antibodies to BVDV in cervids are generally low or absent. A higher prevalence was found in roe deer in Germany (10%: [@CIT0047]) and Norway (12%: [@CIT0048]). The low antibody prevalence (1.3%) against BVDV1 we found does not allow us to suspect maintenance in roe deer and contrasts with the high seroprevalence in Belgian cattle. Spillover from the latter is probable. Distinct pestivirus strains, different from those in domestic animals, have been found in roe deer ([@CIT0049], [@CIT0050]) but need more specialised methods to be detected.

In cattle, VNT and various ELISA tests are used for **BHV1** antibody detection ([@CIT0007], [@CIT0051]). These tests are unable to distinguish between antibodies against BHV1 or BHV1 related herpesviruses due to their antigenic similarity. Weak positive samples may score falsely negative. Combined VNTs against the different related viruses or non-serologic methods such as qPCR are needed for differentiation. The seroprevalence for alphaherpesviruses reported in roe deer in Europe is between 0 and 3% ([@CIT0048], [@CIT0052]). In roe deer, it is generally lower than in red deer, for which between 11 and 29% seropositives were found in Belgium ([@CIT0053], [@CIT0054]) and up to 40% in Scotland ([@CIT0055]). Using combined neutralisation tests, Frölich et al. ([@CIT0056]) found 10.55%, 2.6%, and 5.2% roe deer seropositive for BHV1, caprine herpesvirus 1 (CpHV1), and cervid herpesvirus 1 (CvHV1), respectively. Our results indicate that roe deer are not relevant in the epidemiology of BHV1 and related alphaherpesviruses in Flanders.

The commonly used ELISA tests for **BTV** antibodies all show high specificity and sensitivity in cattle ([@CIT0057]). The competitive ELISA is species independent because the detection system is directed to a generic competitive monoclonal antibody ([@CIT0058]). In a Swiss survey in wild ruminants using cELISA, increasing haemolysis lowered the mean optical density value, implicating a higher probability of false negative results. Yet confirmatory tests to rule out false negative and positive results showed that haemolysis did not significantly affect the outcome ([@CIT0059]). Information about BTV seroprevalence in wild cervids in Europe is scarce but in roe deer up to 5% is reported in epizootic areas ([@CIT0060]). This is much lower than in red deer (in Spain regionally up to 62%; France 47%) in which maintenance of infection is suspected while roe deer appear to be dead-end hosts ([@CIT0061], [@CIT0062]). During the northwestern European epizootic between 2006 and 2008, the seroprevalence in roe deer in Wallonia rose from 0% in 2005 to 2.75% in 2007 and went back to 1.67% in 2008, while in red deer it increased from 1.51% in 2006 to 52.33% in 2007 and back to 33.95% in 2008 ([@CIT0063]). None of our sera was positive for antibodies against BTV, but 5/165 (3%) were 'doubtful'. Based on the foregoing, all the sera can be considered seronegative, according to the fading seroprevalence in roe deer in Wallonia from 2008 on ([@CIT0063]).

Compared to the ELISA test in which cross-reactions with other flaviviruses occur, the RFFIT seroneutralisation test for **TBEV** is highly specific. Neutralising titres obtained by RFFIT show a high correlation with standard tests (plaque reduction test; haemagglutination inhibition), indicating a good sensitivity ([@CIT0009]). The TBEV seroprevalence reported in roe deer in endemic areas in Europe ranges between 9 and 26% ([@CIT0035], [@CIT0064]), with local maxima as high as 50% ([@CIT0065]). In Wallonia, between 2007 and 2009, 12.4% roe deer were found seropositive with ELISA (including 2/5 highly reactive sera showing significant VNT titres) ([@CIT0066]). For Flanders, we found weak positive titres, just above cut-off, in 5.1% of our sera. Disregarding a possible aspecific viral inhibition due to poor quality of the sera (S.Van Gucht, personal communication), this result suggests virus circulation, and accords with the serologic findings in cattle and wild boar. Autochthonous human infection is not reported in Belgium, but 2.6--3.5% of Belgian cattle proved seropositive ([@CIT0008]). Recently, antibodies have also been found in wild boar in Flanders (Roelandt et al., personal communication). The nearly significant difference in seroprevalence between roe deer of different ages (*p*=0.07, highest in animals \<1 year) is in agreement with Gerth et al. 1995 ([@CIT0064]) who suggest most infections occur at an early age.

The massive circulation of **SBV** in 2011 in Belgium was evidenced by a between-herd seroprevalence of almost 100% in sheep and cattle at the end of the first vector season ([@CIT0067]). In domestic ruminants, VNT for **SBV** antibodies has a high specificity and sensitivity ([@CIT0010], [@CIT0068]), but little is known about its performance in roe deer sera. By using a cut-off value of 8, 27.9% of the sera collected over the whole sampling period were positive. By its recent emergence, information about SBV in wild ruminants in Europe is scarce. In The Netherlands, VNT revealed 69% (cut-off 8) and 52% seropositives (cut-off 16) in roe deer submitted for post-mortems ([@CIT0069]). An exponential increase in seropositivity was found in the fall of 2011 in Wallonia in wild cervids (red deer 40%, roe deer 46%) and in France (20%) using ELISA ([@CIT0070], [@CIT0071]). In Flanders, where the circulation of SBV in its *Culicoides* vectors was reported from September 2011 ([@CIT0072]), all sera sampled before October 2011 (period 1) were negative. In the sera collected between January 2012 and March 2013 (period 2), the percentage of positives (63%) was similar to the Walloon sera collected in November 2011 (62.5%). Therefore, seroconversion in Flemish roe deer must have taken place between October and December 2011. In Wallonia, seropositive deer were already found in October 2011 and seropositivity rose to 88.9% in December 2011 ([@CIT0070]). In Flanders, no further follow-up was carried out for SBV in roe deer after March 2013. The high seropositivity for SBV in Flemish roe deer, apparently without any clinical impact, like in Wallonia coincided temporally with the progress of the epizootic in domestic ruminants, and with the presence of infected vectors. Larska et al. ([@CIT0073]) found a higher SBV seroprevalence in roe deer with increasing domestic ruminant density, suggesting spillover from the latter. The density distribution of domestic animals may provide a possible explanation for the close to significant difference in seroprevalence we found between regions (*p*=0.068).

The performances of the iELISA for antibodies to ***T. gondii*** in roe deer appear good because 100% agreement was found between the results of iELISA and MAT ([@CIT0011]). Cross-reactivity with antibodies to the related *N. caninum* is rare ([@CIT0074]). The *T. gondii* seroprevalence found in roe deer in Europe ranges from 13 to 63% ([@CIT0052], [@CIT0075]). In accordance, we found a high prevalence (43.2%) in Flemish roe deer. As cervids are herbivorous, infection with *Toxoplasma* occurs by ingesting oocysts, which supposes contact with cat faeces. Therefore, roe deer, among other wildlife, are important indicators of environmental contamination with *Toxoplasma* oocysts. The small landscape structure of densely populated Flanders and the many domestic and stray cats make heavy contamination probable and could explain the high seropositivity in roe deer sera. Flemish house cats show 20.4% seropositivity (Belgium: 27%) ([@CIT0076]). Wild cats (*Felis silvestris*) are extinct in Flanders.

***N. caninum*** is the most important cause of abortion in Flemish cattle, the herd seroprevalence being 62.5% ([@CIT0022]). In cattle, more than 95% specificity and sensitivity are obtained with the IDVET test ([@CIT0012]). Cross-reactions with *T. gondii* are negligible (cf above). In the few studies carried out in roe deer in Europe, the seroprevalence appears generally low, i.e. between 3 and 14% ([@CIT0052], [@CIT0077]). The 4.8% we found fits within this range. Low seroprevalence to *N. caninum* may reflect rare contacts with domestic dogs, being the end hosts. Contacts with red fox faeces are more probable for roe deer than contact with dog faeces, the red fox being omnipresent in Flanders with often high population densities in multiple small territoria ((regional estimates: up to 3.5/km^2^; K.Van Den Berge, personal communication). If the test is enough sensitive, the low seroprevalence of *N. caninum* antibodies we found in roe deer supports the non-relevance of foxes as *N. caninum* end hosts ([@CIT0078], [@CIT0079]). The significant difference in seroprevalence we observe between ages (*p*=0.026) accords with other studies in which seroprevalence increases with age ([@CIT0080])

Being browsers, roe deer feed on a broad range of wild plants and cultured crops, of which they select those parts with high protein and carbohydrate and low cellulose contents, such as buds, young twigs, and leaves ([@CIT0081]). As food generalists, they take advantage of a broad diversity of natural and cultured biotopes, which explains their near-omnipresence in Europe. Flanders is characterised by an intensive landscape use and urbanisation pressure by which roe deer have adapted to feeding close to livestock and human dwellings, as confirmed by many observations. Still, the antibody prevalences we found in roe deer are largely comparable to those of other surveys in Europe and may depend on local environmental factors as suggested by Boadella et al. ([@CIT0082]).

Briefly, our observations indicate that a reservoir function of roe deer for *C. abortus* and MAP is probable, that despite the enzootic situation in domestic animals, antibodies to *C. burnetii* and BVDV1 are very low and that antibodies to BHV1 are absent. Like elsewhere, roe deer appear important carriers of at least certain genotypes of the tick-borne *A. phagocytophilum*. Roe deer are the main feeding hosts for *I. ricinus* in Europe and, next to climate change ([@CIT0083]), their expansion is thought to be a major driving force in tick abundance at least in some parts of Europe ([@CIT0084]--[@CIT0086]). Therefore, serologic screening in roe deer provides essential information about the circulation of many tick-borne infections in Europe, even those for which they are non-competent hosts like TBEV and *Borellia burgdorfferi*. For the infections transmitted by midges, unknown in northern Europe before the BTV8 epidemic despite the presence of endemic *Culicoides* species, there is no reason to assume that roe deer would play a key role. The seroprevalence to BTV or SBV coincided temporally with the epizootic in domestic ruminants, indicating simultaneous infection or spillover.

In conclusion, roe deer maintain *C. abortus* and MAP in Flanders, but do not seem to play an important role in the epidemiology of the other infectious agents examined. However, continued surveillance in roe deer as sentinels for newly emerging or existing diseases is recommended, because it is the principal large game species in Flanders and relatively easy to access for sampling.
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